Literature DB >> 21370963

The growing popularity of prescription opioid injection in downtown Montréal: new challenges for harm reduction.

Elise Roy1, Nelson Arruda, Phillipe Bourgois.   

Abstract

Starting in 2007, a 2-year study based on ethnographic methodology was carried out downtown Montréal, Canada. A thematic analysis of observational and interview-based notes was conducted. Illicit prescription opioid (PO) use was widespread among street-based participants. Injection was the main mode of PO administration observed among users. Some injection practices such as "doing a wash" could pose new challenges in terms of prevention of infections. More research is needed to examine the role of illicit PO use in the development of opiate addiction and to better understand drug-using contexts that put PO users at risk of infections. The study's limitations are noted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21370963      PMCID: PMC3161198          DOI: 10.3109/10826084.2011.552932

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  34 in total

1.  Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.

Authors:  Stephen Koester; Jason Glanz; Anna Barón
Journal:  AIDS Behav       Date:  2005-03

2.  The transition from injecting to smoking heroin in three Spanish cities. The Spanish Group for the Study of the Route of Heroin Administration.

Authors:  L de la Fuente; G Barrio; L Royuela; M J Bravo
Journal:  Addiction       Date:  1997-12       Impact factor: 6.526

3.  How many people in Canada use prescription opioids non-medically in general and street drug using populations?

Authors:  Svetlana Popova; Jayadeep Patra; Satya Mohapatra; Benedikt Fischer; Jürgen Rehm
Journal:  Can J Public Health       Date:  2009 Mar-Apr

4.  Mortality among street youth.

Authors:  E Roy; J F Boivin; N Haley; N Lemire
Journal:  Lancet       Date:  1998-07-04       Impact factor: 79.321

Review 5.  Theory, method, and power in drug and HIV-prevention research: a participant-observer's critique.

Authors:  P Bourgois
Journal:  Subst Use Misuse       Date:  1999-12       Impact factor: 2.164

6.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

7.  Can home-made injectable opiates contribute to the HIV epidemic among injection drug users in the countries of the former Soviet Union?

Authors:  Nadia Abdala; Jean-Paul C Grund; Yanis Tolstov; Andrei P Kozlov; Robert Heimer
Journal:  Addiction       Date:  2006-05       Impact factor: 6.526

8.  Mechanisms of prescription drug diversion among drug-involved club- and street-based populations.

Authors:  James A Inciardi; Hilary L Surratt; Steven P Kurtz; Theodore J Cicero
Journal:  Pain Med       Date:  2007-03       Impact factor: 3.750

9.  Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000.

Authors:  Catherine Hankins; Michel Alary; Raymond Parent; Caty Blanchette; Christiane Claessens
Journal:  J Acquir Immune Defic Syndr       Date:  2002-08-15       Impact factor: 3.731

10.  Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England.

Authors:  Vivian Hope; Jo Kimber; Peter Vickerman; Matthew Hickman; Fortune Ncube
Journal:  BMC Infect Dis       Date:  2008-09-18       Impact factor: 3.090

View more
  44 in total

Review 1.  Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.

Authors:  Brandon D L Marshall; Traci C Green; Jesse L Yedinak; Scott E Hadland
Journal:  Int J Drug Policy       Date:  2016-02-04

2.  The opioid epidemic and injection drug use: MIPIE and health harms related to the injection of prescription opioids.

Authors:  Pedro Mateu-Gelabert; Honoria Guarino
Journal:  Int J Drug Policy       Date:  2018-04-05

3.  Role of primary care providers in hepatitis C prevention and care: one step away from evidence-based practice.

Authors:  Andreea Adelina Artenie; Julie Bruneau; Annie Lévesque; Jean-Marie Bamvita Wansuanganyi
Journal:  Can Fam Physician       Date:  2014-10       Impact factor: 3.275

4.  Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California.

Authors:  Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; Philippe Bourgois; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

5.  Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City.

Authors:  Pedro Mateu-Gelabert; Honoria Guarino; Lauren Jessell; Anastasia Teper
Journal:  J Subst Abuse Treat       Date:  2014-07-11

6.  Use of a medically supervised injection facility among street youth.

Authors:  Scott E Hadland; Kora DeBeck; Thomas Kerr; Paul Nguyen; Annick Simo; Julio S Montaner; Evan Wood
Journal:  J Adolesc Health       Date:  2014-06-09       Impact factor: 5.012

7.  Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings.

Authors:  Sean M Murphy; Dana Dweik; Sterling McPherson; John M Roll
Journal:  Am J Drug Alcohol Abuse       Date:  2015-01       Impact factor: 3.829

8.  Identifying and describing a cohort effect in the national database of reported cases of hepatitis C virus infection in Canada (1991-2010): an age-period-cohort analysis.

Authors:  Max Trubnikov; Ping Yan; Jane Njihia; Chris Archibald
Journal:  CMAJ Open       Date:  2014-10-01

9.  Non-medical prescription opioid use predicts injection initiation among street-involved youth.

Authors:  Kora DeBeck; Evan Wood; Huiru Dong; Sabina Dobrer; Kanna Hayashi; Julio Montaner; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2016-06-01

10.  "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting.

Authors:  Sarah G Mars; Philippe Bourgois; George Karandinos; Fernando Montero; Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2013-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.